Teniposide or carboplatin in patients with recurrent or advanced cervical carcinoma: A randomized phase II trial

International Journal of Gynecological Cancer

Volumn 8, Issue 4, 1998, Pages 310-314

  Thomsen, T K ^a,b   Pfeiffer, P ^a   Bertelsen, K ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b NONE   (Denmark)

Author keywords

Cervical cancer; Chemotherapy; Recurrence; Response rates; Toxicity

Indexed keywords

CARBOPLATIN; TENIPOSIDE;

ADULT; ADVANCED CANCER; AGED; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEUKOPENIA; NAUSEA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; THROMBOCYTOPENIA; TREATMENT OUTCOME; UTERINE CERVIX CARCINOMA; VOMITING;

EID: 0031666641     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1438.1998.09811.x     Document Type: Article

References (25)

1. Andersen MC, Coulter CAE, Mason WP, Soutter WP, Tidy J. Malignant disease of the cervix. In: Shaw R, Soutter P, Stanton S eds Gynaecology. London: Churchill Livingstone, 1992: 505-518.
2. Alberts DS, Garcia DJ. Salvage chemotherapy in recurrent or refractory squamous cell cancer of the uterine cervix. Semin Oncol 1994; 21 (Suppl. 7): 37-46.
3. Neijt JP. Advances in chemotherapy of gynecologic cancer. Curr Opin Oncol 1994; 6: 531-8.
4. Vermorken JB. The role of chemotherapy in squamous cell carcinoma of the uterine cervix, a review. Int J Gynecol Cancer 1993; 3: 129-42.
5. Buxton EJ. Experience with bleomycin, ifosfamide, and cisplatin in primary and recurrent cervical cancer. Semin Oncol 1992; 19 (Suppl. 5): 9-18.
6. Park RC, Thigpen JT. Chemotherapy in advanced and recurrent cervical cancer. A review. Cancer Suppl 1993; 71 (4): 1446-50.
7. Mohamed E, Piamsomboom S, Kudelka AP, Kavanagh J. Novel treatments of cervical cancer. Int J Gynecol Cancer 1996; 6 (Suppl. 1): 18-27.
8. Omura GA. Chemotherapy for cervix cancer. Semin Oncol 1994; 21: 54-62.
9. Muggia FM, Kelley SL. Teniposide in adult solid tumors: a historical perspective. Semin Oncol 1992; 19 (Suppl. 6): 43-50.
10. Pfeif fer P, Cold S, Bertelsen K, Panduro J, Sandberg E, Rose C. Teniposide in recurrent or advanced cervical carcinoma: a phase II trial in patients not previously treated with cytotoxic therapy. Gynecol Oncol 1990; 37: 230-3.
11. Bonomi P, Blessing JA, Stehman FB, Disaia PJ, Walton L, Major FJ. Randomized trial of three cisplatin dose schedules in squamous carcinoma of the cervix: a gynecologic oncology group study. J Clin Oncol 1985; 3: 1079-85.
12. Thigpen JT, Blessing JA, DiSaia PJ, Fowler WC Jr, Hatch KD. A randomized comparison of a rapid versus prolonged (24hr) infusion of cisplatin in therapy of squamous cell carcinoma of the uterine cervix: A gynecology oncology group study. Gynecol Oncol 1989; 32: 198-202.
13. Morris M, Gershenson DM, Burke TW, Mitchell MF, Levenbak C, Atkinson N, Wharton JT. A phase II study of carboplatin and cisplatin in advanced or recurrent squamous carcinoma of the uterine cervix. Gynecol Oncol 1994; 53: 23-4-8.
14. Muggia FM, Gill I. Role of carboplatin in endometrial and cervical carcinomas. Semin Oncol 1992; 19 (Suppl. 2): 90-3.
15. Muggia FM, Muderspach L. Platinum compunds in cervical and endometrial cancers: Focus on carboplatin. Semin Oncol 1994; 21 (Suppl. 2): 35-41.
16. Ozols RF. Advances in the chemotherapy of gynecologic malignancy. Hematol Oncol 1992; 10: 43-51.
17. Lira-Puerto V, Silva A, Morris M, Martinez R, Groschen S, Canfield-Morales CF, Tenorio F, Muggia F. Phase II trial of carboplatin or iproplatin in cervical cancer. Cancer Chemother Pharmacol 1991; 28: 391-6.
18. World Health Organization. WHO Handbook for reporting results of cancer treatments, WHO Offset Publ No 48, WHO, Geneva, pp 7-8; 14-30, 1979.
19. Kaplan EL, Meier P. Non-parametric estimation from incomplete observations. J Am Statistical Assoc 1958; 53: 457-81.
20. Murad AM, Triginelli SA, Ribalta JCL. Phase II trial of bleomycin, ifosfamide, and carboplatin in metastatic cervical cancer. J Clin Oncol 1994; 12: 55-9.
21. Mcguire WP, Arsenau J, Blessing JA, DiSaia PJ, Hatch KD, Given FT, Teng NNH, Creasman WT. A randomized comparative trial of carboplatin and iproplatin in advanced squamous carcinoma of the uterine cervix: A gynecologic oncology group study. J Clin Oncol 1989; 7: 1462-8.
22. Chambers SK, Lamb L, Kohorn EI, Schwartz PE, Chambers JT. Chemotherapy of recurrent/advanced cervical cancer: Results of the Yale University PBM-PFU Protocol. Gynecol Oncol 1994; 53: 161-9.
23. Long HJ, Cross WG, Wieand HS, Webb MJ, Maillard JA, Kugler JW, Tschetter LK, Cardinal CG, Ebbert LP, Rayson S. Phase II trial of methotrexate, vinblastine, doxorubicin, and cisplatin in advanced/recurrent carcinoma of the uterine cervix and vagina. Gynecol Oncol 1995; 57: 235-9.
24. Obasaju CK, Cowan RA, Wilkinson PM. Recurrent cervical cancer treated with cisplatin and methotrexate. Clin Oncol 1993; 5: 203-6.
25. Stornes I, Mejlholm I, Holm AA. Phase II trial of ifosfamide, 5-fluorouracil, and leucovorin in recurrent uterine cervical cancer. Gynecol Oncol 1994; 55: 123-5.